Mechanisms of Epithelial-Mesenchymal Transition and Prevention of Dispase-Induced PVR by Delivery of an Antioxidant αB Crystallin Peptide
暂无分享,去创建一个
A. Mackay | C. Spee | R. Kannan | P. Sreekumar | Iori Wada | Michael Ip
[1] Shaoqiu He,et al. BzATP Activates Satellite Glial Cells and Increases the Excitability of Dorsal Root Ganglia Neurons In Vivo , 2022, Cells.
[2] S. Reddy,et al. Mechanisms of RPE senescence and potential role of αB crystallin peptide as a senolytic agent in experimental AMD. , 2022, Experimental eye research.
[3] C. Pérez-Novo,et al. Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism , 2021, Frontiers in Pharmacology.
[4] D. Ferrington,et al. Glutathione Metabolism and the Novel Role of Mitochondrial GSH in Retinal Degeneration , 2021, Antioxidants.
[5] S. Sadda,et al. Transporter-Mediated Mitochondrial GSH Depletion Leading to Mitochondrial Dysfunction and Rescue with αB Crystallin Peptide in RPE Cells , 2020, Antioxidants.
[6] Victor G. Puelles,et al. Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS , 2020, EMBO reports.
[7] A. Salminen,et al. The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology , 2019, International journal of molecular sciences.
[8] J. A. MacKay,et al. Intra‐vitreal &agr;B crystallin fused to elastin‐like polypeptide provides neuroprotection in a mouse model of age‐related macular degeneration , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[9] A. M. van der Bliek,et al. Cell Biology of the Mitochondrion , 2017, Genetics.
[10] J. Linton,et al. Biochemical adaptations of the retina and retinal pigment epithelium support a metabolic ecosystem in the vertebrate eye , 2017, bioRxiv.
[11] J. Al-Aama,et al. The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages , 2016, The Journal of cell biology.
[12] D. Hinton,et al. αB-Crystallin Regulates Subretinal Fibrosis by Modulation of Epithelial-Mesenchymal Transition. , 2016, The American journal of pathology.
[13] J. Pastor,et al. Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences , 2016, Progress in Retinal and Eye Research.
[14] D. Hinton,et al. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy , 2015, Scientific Reports.
[15] L. Desai,et al. Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis , 2015, Redox biology.
[16] Shuai Yang,et al. Mechanisms of epithelial-mesenchymal transition in proliferative vitreoretinopathy. , 2015, Discovery medicine.
[17] Zhenna Chen,et al. The roles of signaling pathways in epithelial-to-mesenchymal transition of PVR , 2015, Molecular vision.
[18] S. Mukai,et al. Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor α to promote proliferative vitreoretinopathy. , 2014, The American journal of pathology.
[19] H. Cui,et al. Protein polymer nanoparticles engineered as chaperones protect against apoptosis in human retinal pigment epithelial cells. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[20] Mei Chen,et al. Intravitreal Injection of Normal Saline Induces Retinal Degeneration in the C57BL/6J Mouse. , 2014, Translational vision science & technology.
[21] J. Kopp,et al. TGF-β1 stimulates mitochondrial oxidative phosphorylation and generation of reactive oxygen species in cultured mouse podocytes, mediated in part by the mTOR pathway. , 2013, American journal of physiology. Renal physiology.
[22] J. Garweg,et al. Pathophysiology of proliferative vitreoretinopathy in retinal detachment. , 2013, Survey of ophthalmology.
[23] Wencong Wang,et al. The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice , 2013, International journal of nanomedicine.
[24] V. Ganapathy,et al. Antiapoptotic properties of α-crystallin-derived peptide chaperones and characterization of their uptake transporters in human RPE cells. , 2013, Investigative ophthalmology & visual science.
[25] P. Beer,et al. ANALYSIS OF THE MOLECULAR BIOLOGIC MILIEU OF THE VITREOUS IN PROLIFERATIVE VITREORETINOPATHY , 2013, Retina.
[26] Jing Yu,et al. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis. , 2012, Investigative ophthalmology & visual science.
[27] D. Hinton,et al. Novel roles for α-crystallins in retinal function and disease , 2012, Progress in Retinal and Eye Research.
[28] S. Brownell,et al. Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis* , 2012, The Journal of Biological Chemistry.
[29] D. Hinton,et al. Deficiency of αB crystallin augments ER stress-induced apoptosis by enhancing mitochondrial dysfunction. , 2012, Free radical biology & medicine.
[30] Q. Gao,et al. Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice , 2012, Molecular vision.
[31] Y. Liu,et al. Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy , 2012, Eye.
[32] S. Cole,et al. Mechanism of RPE Cell Death in α-Crystallin Deficient Mice: A Novel and Critical Role for MRP1-Mediated GSH Efflux , 2012, PloS one.
[33] G. Reiser,et al. Phosphorylation of Ser45 and Ser59 of αB‐crystallin and p38/extracellular regulated kinase activity determine αB‐crystallin‐mediated protection of rat brain astrocytes from C2‐ceramide‐ and staurosporine‐induced cell death , 2011, Journal of neurochemistry.
[34] E. Barrón,et al. αB Crystallin Is Apically Secreted within Exosomes by Polarized Human Retinal Pigment Epithelium and Provides Neuroprotection to Adjacent Cells , 2010, PloS one.
[35] E. Wawrousek,et al. alphaB-crystallin regulation of angiogenesis by modulation of VEGF. , 2010, Blood.
[36] A. Doseff,et al. The anti-apoptotic function of human αA-crystallin is directly related to its chaperone activity , 2010, Cell Death and Disease.
[37] S. Kase,et al. Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: Relevance to age-related macular degeneration , 2009, Aging.
[38] You-xin Chen,et al. Connective tissue growth factor as a mediator of intraocular fibrosis. , 2008, Investigative ophthalmology & visual science.
[39] M. Bartoli,et al. Vascular endothelial growth factor in eye disease , 2008, Progress in Retinal and Eye Research.
[40] A. Suburo,et al. Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice. , 2008, The American journal of pathology.
[41] E. Wawrousek,et al. α-Crystallin distribution in retinal pigment epithelium and effect of gene knockouts on sensitivity to oxidative stress , 2007, Molecular vision.
[42] D. Hinton,et al. In vivo models of proliferative vitreoretinopathy , 2007, Nature Protocols.
[43] J. Parel,et al. Experimental Model for Proliferative Vitreoretinopathy by Intravitreal Dispase: Limited by Zonulolysis and Cataract , 2006, Ophthalmologica.
[44] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[45] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[46] A. Suburo,et al. A mouse model of proliferative vitreoretinopathy induced by dispase. , 2002, Experimental eye research.
[47] P. Khaw,et al. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. , 1999, Investigative ophthalmology & visual science.
[48] J. D. Cameron,et al. A new model of proliferative vitreoretinopathy. , 1998, Investigative ophthalmology & visual science.
[49] M. Weller,et al. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis. , 1997, Experimental eye research.
[50] M. Sporn,et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. , 1989, The Journal of clinical investigation.
[51] W. Walther,et al. Real-Time Cell Migration Monitoring to Analyze Drug Synergism in the Scratch Assay Using the IncuCyte System. , 2021, Methods in molecular biology.
[52] H. Kaplan,et al. Role of epithelial-mesenchymal transition in proliferative vitreoretinopathy. , 2016, Experimental eye research.
[53] D. Hinton,et al. Alpha crystallins in the retinal pigment epithelium and implications for the pathogenesis and treatment of age-related macular degeneration. , 2016, Biochimica et biophysica acta.
[54] Jonathan G. Rud,et al. Nuclear targeting of transforming growth factor-beta-activated Smad complexes. , 2005, The Journal of biological chemistry.
[55] R. Derynck,et al. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.
[56] A. Spector,et al. What is alpha crystallin? , 1971, American journal of ophthalmology.